AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14671144 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion (low dose: 30 mU/m2.min, high dose: 200 mU/m2.min) during recombinant human FSH (r-hFSH) administration
Number of subjects: 7
Study 14671144 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/d) treatment for 5 months
Number of subjects: 7
Study 14671144 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone treatment with high-dose insulin infusion
Number of subjects: 7
Study 14671144 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone treatment
Number of subjects: 7
Study 12879116 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0
Study 12879116 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 8606987 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-managed care
Number of subjects: 57
Study 8606987 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 57
Study 1453598 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg OKT3
Number of subjects: 0
Study 1453598 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg or 10 mg OKT3
Number of subjects: 0
Study 1453598 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg OKT3
Number of subjects: 0
Study 1453598 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with OKT3)
Number of subjects: 0
Study 3841206 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal 1000 mg once daily for 14 days
Number of subjects: 13
Study 3841206 — intervention group
Group type: COMPARATOR
Intervention: Diflunisal 500 mg twice daily for 14 days
Number of subjects: 13
Study 30959740 — intervention group
Group type: EXPERIMENTAL
Intervention: Synergy 1 (10 g per day)
Number of subjects: 23
Study 30959740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 30266885 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS cut point of 10 for supratentorial AIS
Number of subjects: 2902
Study 30266885 — intervention group
Group type: EXPERIMENTAL
Intervention: NIHSS cut point of 6 for infratentorial AIS
Number of subjects: 2902
Study 30266885 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis treatment in infratentorial AIS with baseline NIHSS score > 6
Number of subjects: 2902
Study 30266885 — intervention group
Group type: COMPARATOR
Intervention: Functional outcome and symptomatic intracranial hemorrhage
Number of subjects: 2902
Study 27143684 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient intensification of HF therapy
Number of subjects: 8399
Study 27143684 — intervention group
Group type: EXPERIMENTAL
Intervention: ED visit
Number of subjects: 8399
Study 27143684 — intervention group
Group type: EXPERIMENTAL
Intervention: HF hospitalizations
Number of subjects: 8399
Study 27143684 — intervention group
Group type: COMPARATOR
Intervention: Sacubitril/valsartan
Number of subjects: 8399
Study 25585779 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) cream
Number of subjects: 0
Study 25585779 — intervention group
Group type: COMPARATOR
Intervention: Diprobase (D)
Number of subjects: 0
Study 22703382 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day metoprolol
Number of subjects: 29
Study 22703382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 20006592 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (6 mg)
Number of subjects: 27
Study 20006592 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 27
Study 18037099 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. (methoxy polyethylene glycol-epoetin beta) administered intravenously once every 2 weeks
Number of subjects: 181
Study 18037099 — intervention group
Group type: COMPARATOR
Intervention: Epoetin administered 3 times weekly
Number of subjects: 181
Study 18037099 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A.
Number of subjects: 181
Study 18037099 — intervention group
Group type: COMPARATOR
Intervention: Epoetin
Number of subjects: 181
Study 16039618 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT) with antidepressant medication (n = 17)
Number of subjects: 40
Study 16039618 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medication alone (n = 23)
Number of subjects: 40
Study 11237351 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% CMP solution
Number of subjects: 52
Study 11237351 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% CMP solution
Number of subjects: 52
Study 11237351 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone
Number of subjects: 52
Study 11237351 — intervention group
Group type: COMPARATOR
Intervention: Water containing colorant and clouding agent
Number of subjects: 52
Study 9502064 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthening the tibial portion of the sciatic nerve in hip flexion
Number of subjects: 10
Study 8297216 — intervention group
Group type: EXPERIMENTAL
Intervention: DMT 0.05 mg/kg
Number of subjects: 11
Study 8297216 — intervention group
Group type: EXPERIMENTAL
Intervention: DMT 0.1 mg/kg
Number of subjects: 11
Study 8297216 — intervention group
Group type: EXPERIMENTAL
Intervention: DMT 0.2 mg/kg
Number of subjects: 11
Study 8297216 — intervention group
Group type: EXPERIMENTAL
Intervention: DMT 0.4 mg/kg
Number of subjects: 11
Study 8297216 — intervention group
Group type: EXPERIMENTAL
Intervention: DMT (all doses)
Number of subjects: 11
Study 8297216 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 11
Study 3671137 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 ml (5 mg) nebulized metaproterenol
Number of subjects: 60
Study 3671137 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 ml nebulized metaproterenol
Number of subjects: 60
Study 3671137 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 ml nebulized metaproterenol
Number of subjects: 60
Study 3671137 — intervention group
Group type: COMPARATOR
Intervention: 0.0 ml (placebo)
Number of subjects: 60
Study 29023311 — intervention group
Group type: EXPERIMENTAL
Intervention: EDOF prototype lenses
Number of subjects: 57
Study 29023311 — intervention group
Group type: COMPARATOR
Intervention: 1-Day ACUVUE MOIST MULTIFOCAL (1DAMM)
Number of subjects: 57
Study 27446836 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-dose PEG lavage
Number of subjects: 237
Study 27446836 — intervention group
Group type: COMPARATOR
Intervention: Single 4 L PEG lavage
Number of subjects: 237
Study 24647214 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based screening program for depression (2-year program with ongoing educational dissemination for 4 years)
Number of subjects: 900
Study 24647214 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned, but received educational information)
Number of subjects: 900
Study 23809044 — intervention group
Group type: EXPERIMENTAL
Intervention: Household smoking (>10 cigarettes/d)
Number of subjects: 2954
Study 23809044 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased urine cotinine (≥ 30 ng/mg creatinine)
Number of subjects: 2954
Study 23809044 — intervention group
Group type: EXPERIMENTAL
Intervention: Household smoking (1-10 cigarettes/d)
Number of subjects: 2954
Study 21368757 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of gemfibrozil taken 0 hours before repaglinide
Number of subjects: 10
Study 21368757 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of gemfibrozil taken 1 hour before repaglinide
Number of subjects: 10
Study 21368757 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of gemfibrozil taken 3 hours before repaglinide
Number of subjects: 10
Study 21368757 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of gemfibrozil taken 6 hours before repaglinide
Number of subjects: 10
Study 21368757 — intervention group
Group type: COMPARATOR
Intervention: Control: 0.25 mg of repaglinide alone
Number of subjects: 10
Study 19500860 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical levobupivacaine (5 ml, 25 mg/10 ml)
Number of subjects: 51
Study 19500860 — intervention group
Group type: COMPARATOR
Intervention: Saline swabs (5 ml)
Number of subjects: 51
Study 19500860 — intervention group
Group type: COMPARATOR
Intervention: Topical levobupivacaine and saline swabs
Number of subjects: 51
Study 16512756 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement (OFD)
Number of subjects: 30
Study 16512756 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineralized human cancellous bone allograft (MBA)
Number of subjects: 30
Study 16512756 — intervention group
Group type: EXPERIMENTAL
Intervention: MBA with bioabsorbable collagen membrane (GTR+MBA)
Number of subjects: 30
Study 12736016 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperineal biopsy (six cores)
Number of subjects: 107
Study 12736016 — intervention group
Group type: COMPARATOR
Intervention: Transrectal biopsy (six cores)
Number of subjects: 107
Study 12736016 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperineal biopsy
Number of subjects: 107
Study 12736016 — intervention group
Group type: COMPARATOR
Intervention: Transrectal biopsy
Number of subjects: 107
Study 10938568 — intervention group
Group type: EXPERIMENTAL
Intervention: Luria-Nebraska Neuropsychological Battery-Third Edition (LNNB-III) memory scales
Number of subjects: 318
Study 9184518 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrollment in Women, Infants, and Children (WIC) program
Number of subjects: 0
Study 9184518 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninsured status
Number of subjects: 0
Study 9184518 — intervention group
Group type: COMPARATOR
Intervention: Enrollment in Aid to Families with Dependent Children (AFDC) program
Number of subjects: 0
Study 9184518 — intervention group
Group type: COMPARATOR
Intervention: Enrollment in Medicaid program
Number of subjects: 0
Study 8356895 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric day treatment
Number of subjects: 0
Study 8356895 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment
Number of subjects: 0
Study 6498138 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone injection
Number of subjects: 0
Study 6498138 — intervention group
Group type: COMPARATOR
Intervention: Incision and curettage
Number of subjects: 0
Study 31327687 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus pomalidomide and dexamethasone
Number of subjects: 249
Study 31327687 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide and dexamethasone
Number of subjects: 249
Study 29490909 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental donor human milk (DHM)
Number of subjects: 363
Study 29490909 — intervention group
Group type: COMPARATOR
Intervention: Preterm formula (PTF)
Number of subjects: 363
Study 26833348 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir (once-daily)
Number of subjects: 2812
Study 25315404 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-release DMF 240 mg PO BID
Number of subjects: 2301
Study 25315404 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-release DMF 240 mg PO TID
Number of subjects: 2301
Study 25315404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2301
Study 22879964 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary tryptophan depletion (5-HT depleted subjects)
Number of subjects: 0
Study 22879964 — intervention group
Group type: COMPARATOR
Intervention: Non-depleted control group
Number of subjects: 0
Study 20716075 — intervention group
Group type: EXPERIMENTAL
Intervention: cLMA (silicone reusable laryngeal mask)
Number of subjects: 100
Study 20716075 — intervention group
Group type: COMPARATOR
Intervention: Ambu laryngeal mask
Number of subjects: 100
Study 20716075 — intervention group
Group type: COMPARATOR
Intervention: Unique laryngeal mask
Number of subjects: 100
Study 20716075 — intervention group
Group type: COMPARATOR
Intervention: Portex Soft Seal
Number of subjects: 100
Study 20716075 — intervention group
Group type: EXPERIMENTAL
Intervention: Boss Systems single-use laryngeal mask
Number of subjects: 100
Study 17924779 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (100 mg to 300 mg twice daily for 9 weeks)
Number of subjects: 45
Study 17924779 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=15)
Number of subjects: 45
Study 16676341 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive parent training (PT)
Number of subjects: 0
Study 15648400 — intervention group
Group type: EXPERIMENTAL
Intervention: One boiled egg every day for 8 weeks
Number of subjects: 34
Study 11198483 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with POTS
Number of subjects: 49
Study 11198483 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 49
Study 11198483 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with low orthostatic tolerance
Number of subjects: 49
Study 11198483 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with low orthostatic tolerance and healthy controls
Number of subjects: 49
Study 8630638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular meloxicam 15 mg for 7 days
Number of subjects: 211
Study 8630638 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular piroxicam 20 mg for 7 days
Number of subjects: 211
Study 8630638 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular meloxicam 15 mg
Number of subjects: 211
Study 1735394 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 47
Study 1735394 — intervention group
Group type: COMPARATOR
Intervention: Epidural anaesthesia
Number of subjects: 47
Study 6391588 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep muscle relaxation
Number of subjects: 0
Study 6391588 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive training
Number of subjects: 0
Study 6391588 — intervention group
Group type: COMPARATOR
Intervention: Attention/placebo
Number of subjects: 0
Study 6391588 — intervention group
Group type: COMPARATOR
Intervention: No behavioural treatment
Number of subjects: 0
Study 30530801 — intervention group
Group type: COMPARATOR
Intervention: Ibrutinib 420 mg (single agent)
Number of subjects: 208
Study 30530801 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg plus rituximab 375 mg/m2
Number of subjects: 208
Study 30530801 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib plus rituximab
Number of subjects: 208
Study 28376975 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol test cigarette
Number of subjects: 0
Study 28376975 — intervention group
Group type: COMPARATOR
Intervention: Non-menthol test cigarette
Number of subjects: 0
Study 26367064 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot 20%
Number of subjects: 8
Study 26367064 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot 40%
Number of subjects: 8
Study 26367064 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot 80%
Number of subjects: 8
Study 26367064 — intervention group
Group type: EXPERIMENTAL
Intervention: All hot conditions (Hot 20%, Hot 40%, Hot 60%, Hot 80%)
Number of subjects: 8
Study 26367064 — intervention group
Group type: COMPARATOR
Intervention: ADR
Number of subjects: 8
Study 23765198 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Follicular Exercise (EFX)
Number of subjects: 5
Study 23765198 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-Luteal Exercise (MLX)
Number of subjects: 5
Study 21244698 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar yoga
Number of subjects: 60
Study 21244698 — intervention group
Group type: COMPARATOR
Intervention: Wait-list usual care control
Number of subjects: 60
Study 19500859 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Knife Tonsillectomy (PKT)
Number of subjects: 110
Study 19500859 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar Electrocautery (BET)
Number of subjects: 110
Study 19500859 — intervention group
Group type: COMPARATOR
Intervention: Cold Dissection (CDT)
Number of subjects: 110
Study 17174705 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant infusion of 1 g pralidoxime over 1 hour every hour for 48 hours after a 2 g loading dose
Number of subjects: 200
Study 17174705 — intervention group
Group type: COMPARATOR
Intervention: Bolus dose of 1 g pralidoxime over 1 hour every 4 hours for 48 hours after a 2 g loading dose
Number of subjects: 200
Study 14577980 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-mg nicotine polacrilex lozenge
Number of subjects: 0
Study 14577980 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mg nicotine polacrilex lozenge
Number of subjects: 0
Study 14577980 — intervention group
Group type: COMPARATOR
Intervention: Lozenges administered every 90 min
Number of subjects: 0
Study 14577980 — intervention group
Group type: COMPARATOR
Intervention: 4-mg nicotine polacrilex lozenge (used as directed)
Number of subjects: 0
Study 10761819 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian extract (multiple doses over 14 days)
Number of subjects: 16
Study 10761819 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerian extract
Number of subjects: 16
Study 10761819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8774234 — intervention group
Group type: EXPERIMENTAL
Intervention: New calcium-rich fresh cheese
Number of subjects: 12
Study 8774234 — intervention group
Group type: COMPARATOR
Intervention: Traditional commercial fresh cheese
Number of subjects: 12
Study 8774234 — intervention group
Group type: EXPERIMENTAL
Intervention: New calcium-rich fresh cheese with added Fe
Number of subjects: 12
Study 8774234 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral water
Number of subjects: 12
Study 8774234 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral product
Number of subjects: 12
Study 8774234 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral water with spaghetti meal
Number of subjects: 12
Study 1534646 — intervention group
Group type: EXPERIMENTAL
Intervention: SP (morphine‐scopolamine + pancuronium)
Number of subjects: 80
Study 1534646 — intervention group
Group type: EXPERIMENTAL
Intervention: LP (lorazepam + pancuronium)
Number of subjects: 80
Study 1534646 — intervention group
Group type: EXPERIMENTAL
Intervention: SV (morphine‐scopolamine + vecuronium)
Number of subjects: 80
Study 1534646 — intervention group
Group type: EXPERIMENTAL
Intervention: LV (lorazepam + vecuronium)
Number of subjects: 80
Study 6374246 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous instillation of sodium nitroprusside (39 patients)
Number of subjects: 56
Study 6374246 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (17 patients)
Number of subjects: 56
Study 31334882 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based learning modules
Number of subjects: 244
Study 29016548 — intervention group
Group type: EXPERIMENTAL
Intervention: Brochure intervention (n = 72)
Number of subjects: 143
Study 29016548 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention (n = 71)
Number of subjects: 143
Study 27942123 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft lumbosacral orthoses
Number of subjects: 10
Study 27942123 — intervention group
Group type: COMPARATOR
Intervention: Rigid lumbosacral orthoses
Number of subjects: 10
Study 27942123 — intervention group
Group type: COMPARATOR
Intervention: Comparison between soft and rigid lumbosacral orthoses
Number of subjects: 10
Study 24277778 — intervention group
Group type: EXPERIMENTAL
Intervention: Health information leaflets plus lay health trainers' support for 3 months (n = 76)
Number of subjects: 114
Study 24277778 — intervention group
Group type: COMPARATOR
Intervention: Health information leaflets alone (n = 38)
Number of subjects: 114
Study 22952580 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 days of antibiotic treatment
Number of subjects: 225
Study 22952580 — intervention group
Group type: COMPARATOR
Intervention: 15 days of antibiotic treatment
Number of subjects: 225
Study 19702464 — intervention group
Group type: EXPERIMENTAL
Intervention: Less demanding task
Number of subjects: 0
Study 19702464 — intervention group
Group type: EXPERIMENTAL
Intervention: More demanding task
Number of subjects: 0
Study 19702464 — intervention group
Group type: COMPARATOR
Intervention: Control experiment with mask
Number of subjects: 0
Study 19702464 — intervention group
Group type: EXPERIMENTAL
Intervention: Demands of the visual attributes in the demanding task
Number of subjects: 0
Study 17386350 — intervention group
Group type: EXPERIMENTAL
Intervention: telmisartan 80 mg/amlodipine 2.5 mg daily
Number of subjects: 300
Study 17386350 — intervention group
Group type: EXPERIMENTAL
Intervention: telmisartan 120 mg/amlodipine 2.5 mg daily
Number of subjects: 300
Study 17386350 — intervention group
Group type: EXPERIMENTAL
Intervention: telmisartan 160 mg/amlodipine 2.5 mg daily
Number of subjects: 300
Study 17386350 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 5 mg/telmisartan 40 mg daily
Number of subjects: 300
Study 17386350 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 7.5 mg/telmisartan 40 mg daily
Number of subjects: 300
Study 17386350 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 10 mg/telmisartan 40 mg daily
Number of subjects: 300
Study 16623036 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program including aerobic exercise for 8 weeks, 4 days per week, 30 minutes per day at light to moderate intensity.
Number of subjects: 33
Study 16623036 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 33
Study 11237776 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 0
Study 9605370 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT (Percutaneous Dilatational Tracheostomy)
Number of subjects: 60
Study 9605370 — intervention group
Group type: COMPARATOR
Intervention: TR (Conventional Surgical Tracheostomy)
Number of subjects: 60
Study 9605370 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT
Number of subjects: 60
Study 9605370 — intervention group
Group type: COMPARATOR
Intervention: TR
Number of subjects: 60
Study 7817730 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiellands forceps
Number of subjects: 50
Study 7817730 — intervention group
Group type: COMPARATOR
Intervention: Non-rotational forceps (Neville Barnes forceps)
Number of subjects: 50
Study 3411625 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for breast cancer with mammography and clinical examination
Number of subjects: 2
Study 3411625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 2